Loading data
NMRANasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Research and development expense | 176.07 m USD | 200.93 m USD | 142.72 m USD | 91.75 m USD |
| Operating profit | -241.16 m USD | -263.46 m USD | -252.1 m USD | -135.87 m USD |
| Interest expense | 2.01 m USD | — | — | — |
| Profit before tax | -236.8 m USD | -243.6 m USD | -235.66 m USD | -130.9 m USD |
| Income tax expense | 130 k USD | 178 k USD | 268 k USD | — |
| Net income (reported basis) | 236.93 m USD | 243.79 m USD | -235.93 m USD | -130.9 m USD |
| Basic earnings per share | -1.45 USD/share | -1.53 USD/share | -3.63 USD/share | -4.81 USD/share |
| Diluted earnings per share | -1.45 USD/share | -1.53 USD/share | -3.63 USD/share | -4.81 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.